H.R. 5334 · 112th Congress
To amend chapter V of the Federal Food, Drug, and Cosmetic Act to expedite the development and review of breakthrough therapies.
- Stage
- In committee
- Sponsor
- Brian Bilbray
- Introduced
- 2012-05-07
- Latest action
- 2012-05-11 · Referred to the Subcommittee on Health.